from2028 Activists Investors Trump Politicians Serenity Citrini Semianalysis Trade Arbitrage Search

$MYGN:NASDAQ · MYRIAD GENETICS INC

Sector: health

Conviction from: NASDAQ

Myriad Genetics develops and provides molecular diagnostic and genetic tests for hereditary cancer risk, oncology, prenatal, and mental-health applications.

2 tracked filer(s) hold this · 1 opened, 1 added, 0 trimmed in 31-MAR-2026

Aggregate 13FScore 57 — mean of 2 scored holder(s) · buyers (new/add) avg 57. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Louis Bacon / Moore	56	New buy	218,398	$982,791	0.0%
Larry Robbins / Glenview	58	Added +18%	5,411,978	$24,353,901	0.6%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

Filed	Insider	Role	Shares	Value
2026-02-27	Phanstiel S. Louise	director	104,507	$494,548	Form 4

Trump & executive branch trades all Trump/exec trades →

1 disclosed trade(s) by 1 filer(s).

Trade date	Who	Type	Amount
2026-05-14	Trump, Donald J President	SELL	$15,001 - $50,000	PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.